Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2026-04-18 @ 2:33 PM
Study NCT ID:
NCT00376961
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2006-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor:
SWOG Cancer Research Network
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CDR0000494646
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |